An advanced immunopeptidomics platform identifies peptides presented by MHC molecules using mass spectrometry, enabling safer biotherapeutic development and early detection of immunogenic regions. It supports target discovery and validation of designed epitopes, facilitating the advancement of personalized medicine, vaccines, and immunotherapies.